Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
6.98
+0.23 (3.41%)
At close: Aug 13, 2025, 4:00 PM
6.95
-0.03 (-0.43%)
After-hours: Aug 13, 2025, 4:04 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $194.89 million as of August 13, 2025. Its market cap has decreased by -63.92% in one year.
Market Cap
194.89M
Enterprise Value
25.16M
1-Year Change
-63.92%
Ranking
Category
Stock Price
6.98
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $194.89M, a decrease of -51.53%. That is a compound annual growth rate of -41.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 189.28M | -49.88% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |